Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR-14.0%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-14.0%/yr
Quarterly compound
Percentile
P82
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 10.35% |
| Q2 2025 | 2.50% |
| Q1 2025 | 11.58% |
| Q4 2024 | -18.83% |
| Q3 2024 | 9.68% |
| Q2 2024 | -10.48% |
| Q1 2024 | -32.40% |
| Q4 2023 | -40.11% |
| Q3 2023 | -52.48% |
| Q2 2023 | 50.36% |
| Q1 2023 | 7.25% |
| Q4 2022 | -5.10% |
| Q3 2022 | 16.25% |
| Q2 2022 | 2.56% |
| Q1 2022 | 14.08% |
| Q4 2021 | -29.64% |
| Q3 2021 | -25.91% |
| Q2 2021 | -47.02% |
| Q1 2021 | -0.81% |
| Q4 2020 | -22.12% |
| Q3 2020 | -19.51% |
| Q2 2020 | -30.07% |
| Q1 2020 | 0.00% |